Advertisement
Loading...

Jazz Pharmaceuticals plc

JAZZ•NASDAQ
Healthcare
Biotechnology
$231.05
$-1.28(-0.55%)
U.S. Market is Open • 09:43

Jazz Pharmaceuticals plc (JAZZ) Stock Overview

Explore Jazz Pharmaceuticals plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap14.5B
P/E Ratio484.06
EPS (TTM)$0.11
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$168.57
3 Months$169.46
1 Year Target$152.31

JAZZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Jazz Pharmaceuticals plc (JAZZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 72.91, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $152.31.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 484.06 and a market capitalization of 14.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.55%
5-Day Change
1.01%
1-Month Change
14.92%
3-Month Change
38.93%
6-Month Change
63.78%
Year-to-Date (YTD) Change
35.91%
1-Year Change
116.77%
3-Year Change
71.55%
5-Year Change
28.96%
All-Time (Max) Change
1203.16%

Contact Information

https://www.jazzpharma.com
353 1 634 7800
Waterloo Exchange, Dublin, NaN, 4

Company Facts

2,800 Employees
IPO DateJun 1, 2007
CountryIE
Actively Trading

Frequently Asked Questions